{
  "decision_text": "Patient: age 21, primary: Injury to thoracic aorta.\nActionable summary:\n- Proceed with emergent contrast-enhanced CT/CTA immediately.\n- Notify radiology and document renal function and contrast volume.\n- Document discussion of renal risk and obtain consent when practicable; monitor creatinine post-contrast if indicated.",
  "rationale": [
    "eGFR 135.1 \u2014 lower renal risk.",
    "MAP 49.3 mmHg \u2014 haemodynamic compromise.",
    "Life/organ-threatening diagnosis; imaging benefit may outweigh renal risk."
  ],
  "flags": [
    "low_renal_risk",
    "hemodynamic_instability",
    "emergent_imaging_required"
  ],
  "guideline_snippets": [
    {
      "id": "ACR_contrast_manual#18",
      "score": 0.5509134531021118,
      "text": "ACR-NKF Consensus Statement: Use of Intravenous Gadolinium-based Contrast Media in Patients With Kidney Disease"
    },
    {
      "id": "ACR_contrast_manual#17",
      "score": 0.5494996905326843,
      "text": "ACR-NKF Consensus Statement: Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease"
    },
    {
      "id": "ACR_contrast_manual#8",
      "score": 0.44094014167785645,
      "text": "Nephrogenic Systemic Fibrosis (NSF) - Clarification on gadolinium-based contrast agent groups"
    },
    {
      "id": "NICE_NG203_CHRONIC_KIDNEY_DISEASE#38",
      "score": 0.426973819732666,
      "text": "glomerular filtration rate for diagnosing anaemia associated with CKD"
    },
    {
      "id": "ACR_contrast_manual#21",
      "score": 0.4183237552642822,
      "text": "Statement from Drugs and Contrast Media Committee on Supervision of Contrast Material Administration"
    },
    {
      "id": "NICE_NG203_CHRONIC_KIDNEY_DISEASE#4",
      "score": 0.4093932509422302,
      "text": "Kidney conditions"
    }
  ],
  "timestamp": 1754751823.1020515
}